Beam Therapeutics Inc. (BEAM)
BMV
Real-time Data
02:30 PM
Day's Range
439.0052 wk Range
398.00Overview - BEAM - Beam Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
689.43B
P/E (Trailing)
‪-492.59‬
PEG Ratio
‪-27.36‬
Price / Sales (TTM)
‪286.84‬
Price / Book
‪2.32‬
EV / EBITDA
‪-109.51‬
Profitability
Profit Margin
‪-55.44%‬
Operating Margin
‪-25,827.14%‬
Return on Assets
‪-17.01%‬
Return on Equity
‪-8.18%‬
Ownership
Shares Outstanding
103.26M
Float
88.24M
Held by Insiders
‪1.37%‬
Held by Institutions
‪107.80%‬
Price stats
Beta
‪2.22‬
50-Day Avg
‪463.05‬
200-Day Avg
‪528.15‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - BEAM - Beam Therapeutics Inc.
Peers - BEAM - Beam Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- BEAMBMVBeam Therapeutics Inc.41.21BMarket Cap-11.53%52-week change-492.59P/E (Trailing)‪-55.44%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt1.05TMarket Cap+10.77%52-week change36.36P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals, Inc.742.50BMarket Cap-51.02%52-week change53.47P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE American Depositary Share413.38BMarket Cap-18.50%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- ASND1NBMVAscendis Pharma A/S291.08BMarket Cap+3.50%52-week change19.80P/E (Trailing)‪70.84%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.213.89BMarket Cap+10.22%52-week change172.39P/E (Trailing)‪2.14%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals, Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
Profile Summary - BEAM - Beam Therapeutics Inc.
About
Beam Therapeutics Inc. is a biotechnology company focused on developing precision genetic medicines using its proprietary base editing platform. The company works on therapies designed to make targeted, single-letter changes in DNA without creating double-strand breaks, supporting programs aimed at serious genetic and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
